Publishing Papers Not the Objective

Another winning article from today's WSJ Opinion Journal. This time decrying the negative impact of myopic intellectuals and other self righteous do-gooders (labeled "PharmaScolds") who seek any opportunity to drive a wedge between science and industry.

"The pharmascolds systematically discount the difficulties of product development. Meanwhile, each new barrier -- such as the National Institutes of Health's ban on paid consulting for industry -- erected between publicly funded researchers and companies, especially cash-strapped start-ups where many of the breakthroughs occur, slows the progress of potential treatments."